TaiMed is pleased to announce our participation in the BIO 2024 conference in San Diego from June 3-6, 2024. TaiMed will highlight its state-of-the-art HIV therapies, including our commercialized product, a promising long-acting combination therapy, and a cutting-edge ADC.

In addition to our therapeutic innovations, TaiMed offers comprehensive CDMO services tailored to meet the unique needs of our partners. Visit us at booth #5643 to explore potential collaborations and learn more about how TaiMed can help your product move from bench to commercialization.

BIO 2024 is an excellent opportunity for us to connect with industry peers and share our latest developments. We look forward to seeing you there!